Radiotherapy and cystectomy for T3 bladder carcinoma

Area of Science:

• Uro-oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Locally advanced bladder cancer (T3 transitional cell carcinoma) presents a significant treatment challenge.
• Current treatment paradigms involve pre-operative radiotherapy followed by radical cystectomy.
• Prognosis is often linked to treatment response and tumor characteristics post-therapy.

Purpose of the Study:

• To analyze the survival outcomes of 102 patients with T3 bladder cancer treated with pre-operative radiotherapy and radical cystectomy.
• To determine the impact of tumor down-staging, assessed by depth of infiltration, on patient survival.
• To evaluate the relative importance of tumor response to radiotherapy versus treatment intensity (dose, cystectomy) on survival.

Main Methods:

• Retrospective analysis of 102 patients with T3 transitional cell carcinoma of the bladder.
• Treatment involved pre-operative radiotherapy and radical cystectomy.
• Survival rates were correlated with the degree of tumor down-staging in the surgical specimen.

Main Results:

• Five-year survival was 60% in patients demonstrating tumor down-staging.
• Survival dropped to 30% for patients with persistent deeply invasive tumor at cystectomy.
• Tumor response to initial radiotherapy appeared to be the primary determinant of survival.

Conclusions:

• Tumor down-staging following pre-operative radiotherapy is a critical predictor of improved survival in T3 bladder cancer.
• The response of T3 bladder cancer to initial radiotherapy is more influential on survival than radiation dose or the addition of cystectomy.
• Survival for locally advanced bladder cancer remains poor, necessitating exploration of novel and more effective therapeutic strategies.